Genitourinary Cancer,Prostate Cancer Nivolumab + Rucaparib for Treating Patients With mCRPC May 02, 2023
Genitourinary Cancer,Prostate Cancer Improving Outcomes in mCRPC: Cabozantinib and Atezolizumab Combination Therapy May 02, 2023
Genitourinary Cancer,Prostate Cancer Exploring the Efficacy of 177Lu-PSMA-617 in Metastatic Castrate-Resistant Prostate Cancer May 02, 2023
Genitourinary Cancer,Prostate Cancer Rezvilutamide vs Bicalutamide + ADT for Hormone Sensitive Prostate Cancer May 02, 2023
Genitourinary Cancer,RCC (Renal Cell Carcinoma) Comparing Perioperative Nivolumab vs Observation in RCC Patients Undergoing Nephrectomy: PROSPER Phase 3 Study Apr 17, 2023
Genitourinary Cancer,RCC (Renal Cell Carcinoma) Phase 2 LITESPARK-004: Belzutifan, a HIF-2α Inhibitor, for VHL Disease-Associated Neoplasms Apr 17, 2023
Genitourinary Cancer,RCC (Renal Cell Carcinoma) Telaglenastat Plus Cabozantinib vs. Placebo Plus Cabozantinib in Advanced RCC Patients:CANTATA Phase 2 Trial Apr 17, 2023
Genitourinary Cancer,RCC (Renal Cell Carcinoma) Phase III NKTR-214: BEMPEG Results: BEMPEG and NIVO vs. Sunitinib or Cabozantinib in RCC Apr 17, 2023
